Evidence map›Paper›PMID 25097083›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2014

Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner.

Johan Nordgren, Sumit Sharma, Filemon Bucardo, Waqas Nasir, Gökçe Günaydın, Djeneba Ouermi, Leon W Nitiema, Sylvia Becker-Dreps, Jacques Simpore, Lennart Hammarström and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 1 synthesis or guideline pooled it, 221 citations in OpenAlex.

  1. Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Non-Secretor Status Due toMicroorganisms · 2025
    Article
  17. Review
  18. Article
  19. Review
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Johan NordgrenDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Medical Faculty, Linköping University, Sweden.
Sumit SharmaDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Medical Faculty, Linköping University, Sweden.
Filemon BucardoDepartment of Microbiology, University of León, Nicaragua.
Waqas NasirDepartment of Clinical Chemistry and Transfusion Medicine, Sahlgrenska Academy at the University of Gothenburg.
Gökçe GünaydınDepartment of Laboratory Medicine, Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden.
Djeneba OuermiCentre de Recherche Biomoléculaire Pietro Annigoni Saint Camille CERBA/LABIOGENE, Université de Ouagadougou, Burkina Faso.
Leon W NitiemaCentre de Recherche Biomoléculaire Pietro Annigoni Saint Camille CERBA/LABIOGENE, Université de Ouagadougou, Burkina Faso.
Sylvia Becker-DrepsDepartment of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill.
Jacques SimporeCentre de Recherche Biomoléculaire Pietro Annigoni Saint Camille CERBA/LABIOGENE, Université de Ouagadougou, Burkina Faso.
Lennart HammarströmDepartment of Laboratory Medicine, Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden.
Göran LarsonDepartment of Clinical Chemistry and Transfusion Medicine, Sahlgrenska Academy at the University of Gothenburg.
Lennart SvenssonDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Medical Faculty, Linköping University, Sweden.
Linköping University · SEUniversité Joseph Ki-Zerbo · BFKarolinska Institutet · SEUniversity of Gothenburg · SEUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe live oral rotavirus (RV) vaccines have shown a reduced efficacy in Africa. Recent in vitro studies have shown binding of the RV surface protein (VP4) to histo-blood group antigens (HBGAs) in an RV genotype-dependent manner, suggesting them to be putative receptors for RV. The diversity of HBGA phenotypes in different ethnic populations, combined with prevalence/absence of specific RV genotypes, led us to hypothesize whether the genetic variations in HBGAs in a population limit susceptibility to certain RV genotypes, plausibly leading to reduced vaccine efficacy.

methodsAssociation between HBGAs status and susceptibility to RV P genotypes was investigated in children in Burkina Faso and Nicaragua. In total, 242 children with diarrhea in Burkina Faso and Nicaragua were investigated, 93 of whom were RV positive.

resultsIn Burkina Faso, the P[8] RV strains (n = 27) infected only Lewis- and secretor-positive children (27/27; P < .0001), but no Lewis-negative children. In contrast, the P[6] strains (n = 27) infected predominantly Lewis-negative children (n = 18; P < .0001) but also Lewis-positive children, irrespective of their secretor status. The results from Nicaragua confirmed that all P[8]-infected children (n = 22) were secretor Lewis positive.

conclusionsAs VP4 of genotype P[8] is a component of current RV vaccines, our finding that Lewis-negative children are resistant to P[8] strains provides a plausible explanation for the reduced vaccine efficacy in populations with a high percentage of Lewis-negative individuals, such as in Africa. Furthermore, our findings provide a plausible explanation as to why P[6] RV strains are more common in Africa.

Indexed as

ABO Blood-Group SystemBurkina FasoChild, PreschoolGenetic Predisposition to DiseaseHumansInfantInfant, NewbornLewis Blood Group AntigensNicaraguaRotavirusRotavirus InfectionsABO Blood-Group SystemLewis Blood Group Antigenshisto–blood group antigenLewisrotavirussusceptibilityvaccine

Identifiers

PMID25097083
PMCPMC4650770
OpenAlexW2041200643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.